Tag | Content |
---|
EnhancerAtlas ID | HS034-17874 | Organism | Homo sapiens | Tissue/cell | ECC-1 | Coordinate | chr2:217656680-217657960 | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_51644 | chr2:217655912-217658498 | Skeletal_Muscle |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH02I216791 | chr2 | 217656033 | 217658378 |
| Enhancer Sequence | TTTCTGTGTG GCTCCTTTCC CACCATTGAT GCTGACATTC TGGCCCCTGA ATACCCATTT 60 CATTGGTACC AAATGGAAAA GCCCCTGGAG GGGAGGATGC CTGGGATGAG GGGGAGGGTA 120 GCTGATGGGG CTCTCGAGAT AGCCCTGGTT CGTCTCTCCC AAGACTAGTT CTCATGCCAA 180 AGGATTCTTG TGTCTCAACC CATGAGATCT GTGGGGCTAC AATTCCAGTT TCTTCTTTCT 240 TTGGCTTCAG TACTTTCCAG CTCCAGTCTC TTGAGGTTAG GGTGTATGTG ACGGGGAGAG 300 GAGACTGGGG CAAGGGGTGG GGAGTTGAGT GGAGTGGGTG GTTGGTAATA TTTTCCAGTT 360 CTTTCTAAAG TGTCTGCCTT CCCTTAATGG ATACGGAAGT GAGCCAGCCA GCTGACTGCC 420 CCGACTGCAA GATTGGTTAC TGCTTACATC ATCTGAGCAG CCAGACTGGG GACAGGGGTG 480 GTGGGGAGGT GGAGGAGAAG CTGAGCAGGG ATTAATCCAG CCCTGAATGA ATTAATAGAC 540 AAAGGCATTG GAGATCAGGT AACCTTTTTC CCAAGCTCAT GCCCTGGGGA TGTGGAGAAG 600 AGCCAGACAG TTCCATTAGT GCATGCATGG CGTGCTCTGT GGGTGCTCCG CCCTTTATCA 660 ACATTTCAGT TCCATTCCAT TGCACCCTAT GCCTCTCCAG TCTGTGAGCT TTGGTTGAGA 720 ATCAGGAATG TCCCAAGAAT ATATTAGTGG AGGAGTGATA TAGAGAGATC TAAGATTAAC 780 AGCCCTCTTG GCATTCCCTT TTAGAGGGGG CCAGCAACCT GCATCAGTTA GCTTTTGCAT 840 GATGAGCTAC CCCTAGCGTT AGCGATGTCT GACAACATTC CTTCATCACT GCTGCGGAGT 900 CTGCAAACCA GCAGGGCAGG CCTGCTGAAT CAGATTGGGC TCTGTGGCTC TTGGCTGCAC 960 TTGCTTAAGT GTTTGTAGGC TGGCTGATGG GCCAGGCTGG TCAGTGATAG CCTGGATGAC 1020 TGGAGCCTTT CTCTGCATAC TCTCTCATCC TCTCCCAGGC AGACTTGAGC TTGCTCAGGT 1080 GGCAGAGGCA GGGTTCCAAG GAGGCAAGGG GCAGCCTGCA AAGCCTCTAG AAGACAGGCT 1140 TAGAATACAT GTAACATGTT CTGTTGGCCA CAGCAAGTTA CAGGGCCAAA GCCGGCAGTG 1200 GGGAAGAGCT CCAGCTCTTG ATGAGAGTAG GGGAAAAGAA ATGCAGACAT TTCTGCACTC 1260 TGCTTTAGAC ACACGCACCC 1280
|
| |
|
|
|